Latin America's Pharma-Bio Industry Sees Favorable Project Activity Throughout Pandemic, an Industrial Info Market Brief
Latin America's Pharma-Bio Industry Sees Favorable Project Activity Throughout Pandemic, an Industrial Info Market Brief
Attachment: pharma
Out of the more than 1,000 capital and maintenance Pharma-Bio Industry projects in Latin America, worth more than $10 billion, that Industrial Info has been monitoring since the pandemic outbreak settled in the region back in March, only 10 projects have been placed on hold, and 16 projects have been cancelled. Grassroot projects lead the investment, with 55 projects worth more than $6 billion, followed by 276 expansion projects for more than $2 billion.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
